Wang L, Wang S, Zhang X, Jia Z. Impact of regions with COVID-19 cases on COVID-zero regions by population mobility—worldwide, 2021. China CDC Wkly. 2022;4:79–82.
Sachs JD, Karim SSA, Aknin L, Allen J, Brosbøl K, Colombo F, et al. The Lancet Commission on lessons for the future from the COVID-19 pandemic. Lancet. 2022;400:1224–80.
Wang X, Cai Y, Zhang B, Zhang X, Wang L, Yan X, et al. Cost-effectiveness analysis on COVID-19 surveillance strategy of large-scale sports competition. Infect Dis Poverty. 2022;11:32.
Larkin HD. Global COVID-19 death toll may be triple the reported deaths. JAMA. 2022;327:1438.
Guan D, Wang D, Hallegatte S, Davis SJ, Huo J, Li S, et al. Global supply-chain effects of COVID-19 control measures. Nat Hum Behav. 2020;4:577–87.
Polonsky JA, Bhatia S, Fraser K, Hamlet A, Skarp J, Stopard IJ, et al. Feasibility, acceptability, and effectiveness of non-pharmaceutical interventions against infectious diseases among crisis-affected populations: a scoping review. Infect Dis Poverty. 2022;11:14.
Barouch DH. Covid-19 vaccines—immunity, variants, boosters. N Engl J Med. 2022;387:1011–20.
Guo Q, Ruhan A, Liang L, Zhao X, Deng A, Hu Y, et al. An imported case of BA.2 lineage of Omicron variant COVID-19—Guangdong Province, China, December 28, 2021. China CDC Wkly. 2022;4:98–9.
Hu T, Zhang M, Deng A, Zhang Y, Li B, Li Y, et al. Comparison of Omicron and Delta variant infection COVID-19 cases—Guangdong Province, China, 2022. China CDC Wkly. 2022;4:385–8.
Young M, Crook H, Scott J, Edison P. Covid-19: virology, variants, and vaccines. BMJ Med. 2022;1: e000040.
Planas D, Saunders N, Maes P, Guivel-Benhassine F, Planchais C, Buchrieser J, et al. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature. 2022;602:671–5.
Bilinski A, Emanuel EJ. COVID-19 and excess all-cause mortality in the US and 18 comparison countries. JAMA. 2020;324:2100–2.
Jørgensen SB, Nygård K, Kacelnik O, Telle K. Secondary attack rates for Omicron and Delta variants of SARS-CoV-2 in Norwegian households. JAMA. 2022;327:1610–1.
Zheng B, Zhu W, Pan J, Wang W. Patterns of human social contact and mask wearing in high-risk groups in China. Infect Dis Poverty. 2022;11:69.
Pan J, Zhu W, Tian J, Liu Z, Xu A, Yao Y, et al. Vaccination as an alternative to non-drug interventions to prevent local resurgence of COVID-19. Infect Dis Poverty. 2022;11:36.
Puhach O, Adea K, Hulo N, Sattonnet P, Genecand C, Iten A, et al. Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2. Nat Med. 2022;28:1491–500.
Bar-On YM, Goldberg Y, Mandel M, Bodenheimer O, Amir O, Freedman L, et al. Protection by a fourth dose of BNT162b2 against Omicron in Israel. N Engl J Med. 2022;386:1712–20.
Arbel R, Wolff Sagy Y, Hoshen M, Battat E, Lavie G, Sergienko R, et al. Nirmatrelvir use and severe Covid-19 outcomes during the Omicron surge. N Engl J Med. 2022;387:790–8.
Davies NG, Kucharski AJ, Eggo RM, Gimma A, Edmunds WJ, Centre for the Mathematical Modelling of Infectious Diseases COVID-19 working group. Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study. Lancet Public Health. 2020;5:e375-85.
Huang Z, Xu S, Liu J, Wu L, Qiu J, Wang N, et al. Effectiveness of inactivated and Ad5-nCoV COVID-19 vaccines against SARS-CoV-2 Omicron BA.2 variant infection, severe illness, and death. BMC Med. 2022;20:400.
He G, Zeng F, Xiao J, Zhao J, Liu T, Hu J, et al. When and how to adjust non-pharmacological interventions concurrent with booster vaccinations against COVID-19—Guangdong, China, 2022. China CDC Wkly. 2022;4:199–206.
Zhou F, Hu TJ, Zhang XY, Lai K, Chen JH, Zhou XH. The association of intensity and duration of non-pharmacological interventions and implementation of vaccination with COVID-19 infection, death, and excess mortality: natural experiment in 22 European countries. J Infect Public Health. 2022;15:499–507.
Zu J, Li ML, Li ZF, Shen MW, Xiao YN, Ji FP. Transmission patterns of COVID-19 in the mainland of China and the efficacy of different control strategies: a data- and model-driven study. Infect Dis Poverty. 2020;9:83.
Chen M, Ai L, Huang D, Chen J, Feng T, Mei S, et al. Soaring asymptomatic infected individuals bring about barriers and difficulties for interruption of COVID-19 prevalence in China. Vector Borne Zoonotic Dis. 2021;21:777–84.
Zhang SX, Yang M, Zheng JX, Zhang BQ, Pan CH, Tian LG. Comprehensive strategies and measures to control COVID-19. Infect Dis Poverty. 2022;11:67.
Chen Z, Deng X, Fang L, Sun K, Wu Y, Che T, et al. Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: a descriptive study. Lancet Reg Health West Pac. 2022;29: 100592.
Ye L, Li WF, Shao J, Xu Z, Ju J, Xu H. Fighting Omicron epidemic in China: real-world big data from Fangcang shelter hospital during the outbreak in Shanghai 2022. J Infect. 2022;85:436–80.
Fan Y, Li X, Zhang L, Wan S, Zhang L, Zhou F. SARS-CoV-2 Omicron variant: recent progress and future perspectives. Signal Transduct Target Ther. 2022;7:141.
Sherratt K, Abbott S, Meakin SR, Hellewell J, Munday JD, Bosse N, et al. Exploring surveillance data biases when estimating the reproduction number: with insights into subpopulation transmission of COVID-19 in England. Philos Trans R Soc Lond B Biol Sci. 2021;376:20200283.
Jin S, Dickens BL, Lim JT, Cook AR. EpiRegress: a method to estimate and predict the time-varying effective reproduction number. Viruses. 2022;14:1576.
Ganyani T, Kremer C, Chen D, Torneri A, Faes C, Wallinga J, et al. Estimating the generation interval for coronavirus disease (COVID-19) based on symptom onset data, March 2020. Euro Surveill. 2020;25:2000257.
Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020;172:577–82.
Mefsin YM, Chen D, Bond HS, Lin Y, Cheung JK, Wong JY, et al. Epidemiology of infections with SARS-CoV-2 Omicron BA.2 variant, Hong Kong, January–March 2022. Emerg Infect Dis. 2022;28:1856–8.
Wu Y, Kang L, Guo Z, Liu J, Liu M, Liang W. Incubation period of COVID-19 caused by unique SARS-CoV-2 strains: a systematic review and meta-analysis. JAMA Netw Open. 2022;5: e2228008.
Yuan P, Tan Y, Yang L, Aruffo E, Ogden NH, Yang G, et al. Assessing the mechanism of citywide test-trace-isolate Zero-COVID policy and exit strategy of COVID-19 pandemic. Infect Dis Poverty. 2022;11:104.
Li X, Zhang Z, Lyu K, Xu D. Strengthening community defenses to prevent and control the spread of COVID-19 in China. China CDC Wkly. 2022;4:191–4.
Erikstrup C, Laksafoss AD, Gladov J, Kaspersen KA, Mikkelsen S, Hindhede L, et al. Seroprevalence and infection fatality rate of the SARS-CoV-2 Omicron variant in Denmark: a nationwide serosurveillance study. Lancet Reg Health Eur. 2022;21: 100479.
Wolter N, Jassat W, Walaza S, Welch R, Moultrie H, Groome M, et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet. 2022;399:437–46.
COVID-19 Excess Mortality Collaborators. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21. Lancet. 2022;399:1513–36.
Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM, Lifelines Corona Research Initiative. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022;400:452–61.
Jain R, Dupas P. The effects of India’s COVID-19 lockdown on critical non-COVID health care and outcomes: evidence from dialysis patients. Soc Sci Med. 2022;296: 114762.
Zou H, Shu Y, Feng T. How Shenzhen, China avoided widespread community transmission: a potential model for successful prevention and control of COVID-19. Infect Dis Poverty. 2020;9:89.
Kong L, Duan M, Shi J, Hong J, Zhou X, Yang X, et al. Optimization of COVID-19 prevention and control measures during the Beijing 2022 Winter Olympics: a model-based study. Infect Dis Poverty. 2022;11:95.
Kucharski AJ, Klepac P, Conlan AJK, Kissler SM, Tang ML, Fry H, et al. Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study. Lancet Infect Dis. 2020;20:1151–60.
Lefrançois T, Malvy D, Atlani-Duault L, Benamouzig D, Druais PL, Yazdanpanah Y, et al. After 2 years of the COVID-19 pandemic, translating One Health into action is urgent. Lancet. 2022. https://doi.org/10.1016/S0140-6736(22)01840-2.
Han E, Tan MMJ, Turk E, Sridhar D, Leung GM, Shibuya K, et al. Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe. Lancet. 2020;396:1525–34.
Gandjour A. Cost-effectiveness of future lockdown policies against the COVID-19 pandemic. Health Serv Manage Res. 2022. https://doi.org/10.1177/09514848221080687.
Reddy KP, Shebl FM, Foote JHA, Harling G, Scott JA, Panella C, Fitzmaurice KP, et al. Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study. Lancet Glob Health. 2021;9:e120–29.
Nuñez MA, Pauchard A, Ricciardi A. Invasion science and the global spread of SARS-CoV-2. Trends Ecol Evol. 2020;35:642–5.
Fei SW, Gu SY, Chen FM, Zhou N, Cheng ZL, Xie Y, et al. Towards a global One Health index: a potential assessment tool for One Health performance. Infect Dis Poverty. 2022;11:57.
Li Q, Bergquist R, Grant L, Song JX, Feng XY, Zhou XN. Consideration of COVID-19 beyond the human-centred approach of prevention and control: the ONE-HEALTH perspective. Emerg Microb Infect. 2022;11:2520–8.
Zhang XX, Liu JS, Han LF, Simm G, Guo XK, Zhou XN. One Health: new evaluation framework launched. Nature. 2022;604(7907):625.